John Stoltzfus, Oppenheimer Asset Management chief investment strategist, joins CNBC's 'Power Lunch' to discuss market ...

Fintel reports that on January 14, 2025, Oppenheimer upgraded their outlook for A. O. Smith (NYSE:AOS) from Perform to ...

As previously reported, Oppenheimer analyst Bryan Blair upgraded A.O. Smith (AOS) to Outperform from Perform with an $88 price target given the ...

Oppenheimer analysts reaffirmed Snowflake (NYSE:SNOW) as a top pick for 2025, driven by strong expectations for the company’s performance and strategic growth initiatives.

Financial-services firm Oppenheimer upgrades A.O. Smith (AOS) to Outperform, citing undervaluation and potential for profit growth.

Equities face a challenging 2025 despite favorable economic conditions, according to Goldman Sachs strategist Peter ...

Oppenheimer Asset Management came out on Monday and argued that investors should not panic as the market's recent downswing ...

Snowflake ( SNOW 0.79%) stock is gaining ground in Tuesday's trading. The company's share price was up 0.5% as of 3:30 p.m. ET and had been up as much 4.8% earlier in the session. Meanwhile, the S&P ...

Hollywood’s awards season has all but come to a rare halt as the wildfires continue to disrupt life and work in the Los ...

La temporada de premios de Hollywood ha llegado a un raro vacío mientras los incendios forestales continúan perturbando la ...

Oppenheimer initiated coverage of Compugen (CGEN) with an Outperform rating and $4 price target. With a sole oncology focus, Compugen is ...

Apple / Universal. When Killers Of The Flower Moon first released in theaters and then later on Apple TV, I found the runtime ...